European Medicines Agency website on suspected side effect reports now in all 23 EU official languages
- Details
- Category: EMA

European Medicines Agency boosts EU transparency
- Details
- Category: EMA

FDA approves generic versions of blood thinner Plavix
- Details
- Category: FDA

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
- Details
- Category: FDA

FDA approves first Boniva generics to treat or prevent osteoporosis
- Details
- Category: FDA

FDA announces safety changes in labeling for some cholesterol-lowering drugs
- Details
- Category: FDA

FDA acts to bolster supply of critically needed cancer drugs
- Details
- Category: FDA

More Pharma News ...
- European Medicines Agency and United States Food and Drug Administration to share manufacturing site inspections
- FDA approves first generic version of cholesterol-lowering drug Lipitor
- Drug not Shown to be Safe and Effective in Breast Cancer Patients
- European Medicines Agency starts new review of cardiovascular risks of non-selective NSAIDs
- European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix
- European Medicines Agency completes its review of Avastin used in breast cancer
- FDA begins process to remove breast cancer indication from Avastin label